Technology

We are happy to announce that the 5th edition of Pumping Insulin is finally at the printers! Books will be shipped to all of our preorder customers in the first week of June. If you haven't ordered yet, order today for only $19.55

Pumping Insulin 5th Edition provides up-to-date information on how to use the smart pump for the best blood glucose management.

The Aviva Blood Glucose Test Strips are now known as Aviva Plus Blood Glucose Test Strips. These new strips will work with your existing Aviva Blood Glucose Meter. Our current prices for Aviva test strips are:

$37.50 for 50 Test Strips

Due to complaints about glucose meter inaccuracy, the Food and Drug Administration (FDA) is currently developing a new standard for glucose meter accuracy. This update is driven by ongoing improvements in meter accuracy, the need for better accuracy with today's pumps, bolus calculators, and continuous glucose monitors, reports of hospital and out-patient deaths, consumer complaints, and research studies showing that several approved glucose meters failed to meet FDA or International Standards Organization (ISO) standards in post-approval testing.(^1-3)

Insulet and Johnson & Johnson announced an agreement to incorporate the OneTouch technology into the Omnipod's remote controller. The next Omnipod will have a built in blood glucose meter in the PDM, allowing you to carry one less device. Insulet already has a deal with Abbott Diabetes Care to include their Freestyle technology in their new PDM but the deal isn't exclusive. Upon release, Insulet could decide to have a separate device for each blood glucose meter technology or switch to Lifescan exclusively after the Abbott deal expires in 2013.

The Food and Drug Administration has reached an agreement with medical device makers that should increase the speed in which they evaluate new devices. The much maligned approval process has long been thought to be slow and unpredictable. For the last decade, the FDA has accepted company payments to supplement it's budget and create a smoother process, totaling $295 million in the last agreement. This new deal raises that budget to $595 million over the next five years, allowing the FDA to hire 200 new scientist.

DexCom and Tandem Diabetes Care have a CGM Development and Commercialization Agreement to integrate the Dexcom's future generation sensor into the t:slim Insulin Delivery System. The t:slim, the first touch-screen insulin pump, has FDA approval but is not on the market yet. The announcement also mentions "future generations of the sensor", so it may be awhile before we see the systems actually working together.

The Diabetes Mall now has Accu-Chek Aviva Test Strips available! You can get 50 strips for $37.50, 100 strips for $68.50, and 150 strips for $111.50. These easy to handle test strips fill quickly with a tiny drop of blood. The Aviva test strips work with the Accu-Chek blood glucose meter.

Medtronic received FDA approval to sell the mySentry Remote Glucose Monitor in the U.S. on January 4, 2012. This remote monitor allows the parents of a child with diabetes to see their child’s continuous glucose monitor (CGM) data during the night from a Paradigm Revel insulin pump while they sleep in another room.

The iBGStar Blood Glucose Monitoring System by AgaMatrix received U.S. Food and Drug Administration (FDA) approval on December 7, 2011. It became available for purchase on May 2, 2012.

Tandem Diabetes Care, Inc. received U.S. Food and Drug Administration (FDA) approval on 11/16/11 to market the t:slim Insulin Delivery System. The t:slim is one of the first insulin pumps to be cleared under the FDA’s new Infusion Pump Improvement Initiative. It has a revolutionary pump system powered by pressure with a microdosing mechanism that can deliver doses as small as 0.001 u.